SCHEMBL19766504

SCHEMBL19766504

CC(C)N1CCC(C)C2(CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19734247 0.92 HRH3 (0.30) —
SCHEMBL19734248 0.90 HRH3 (0.32) —
SCHEMBL14546271 0.86 HRH3 (0.33) —
SCHEMBL22306023 0.82 — —
SCHEMBL19756463 0.78 — —
SCHEMBL19121846 0.78 — —
SCHEMBL14252348 0.78 — —
SCHEMBL19756472 0.78 — —
SCHEMBL24734691 0.78 HRH3 (0.33) —
SCHEMBL19727297 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030885-B2 Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors INCYTE CORPORATION (US) 2024-07-09 — — US disclosed
US-20180009816-A1 HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS INCYTE CORPORATION 2018-01-11 — — US disclosed
Send feedback